Sveriges Riksbank
| Bid date, 2021-02-19 | |
| Bid Submission Date | 2021-02-19 |
| Bid times | 10.30-11.00 (CET/CEST) on the Bid date |
| Offered Amount | 50 billion SEK |
| Maximum Permitted Bid Volume | 12.5 billion SEK from an individual bidder |
| Settlement Date | 2021-02-23 |
| Minimum Permitted Bid Volume | 10 million SEK per bid |
| Final Repayment Date | 2025-02-24 |
| Maximum Allocation | 25 per cent of Offered Amount |
| Allocation Time | Not later than 11.30 (CET/CEST) on the Bid date |
| Repayment Date | 2022-02-23 |
| Option Repayment Date 1 | 2023-02-23 |
| Option Repayment Date 2 | 2024-02-23 |
| Interest rate | The Riksbank´s applicable repo rate |
| Additional interest rate | 0.10 per cent |
| Confirmation of bids to e-mail | eol@riksbank.se |
Stockholm, 2021-02-17
This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
King Faisal Prize7.1.2026 19:01:34 CET | Press release
Pioneering Scientist Behind Revolutionary Weight-Loss Drugs and Leading Mathematician Honored with 2026 King Faisal Prize
Herantis Pharma plc7.1.2026 19:01:06 CET | Press release
Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease
Theon International PLC7.1.2026 18:43:56 CET | Press release
THEON completes the acquisition of a circa 9.8% stake in Exosens
Modelo7.1.2026 18:41:51 CET | Press release
UPDATE - Big Flavor, Zero Compromise: Modelo® Debuts First-Ever Non-Alcoholic Option
VALLOUREC7.1.2026 18:00:00 CET | Press release
VALLOUREC INITIATES A €200 MILLION SHARE BUYBACK AND TARGETS TOTAL SHAREHOLDER RETURN TO BE AT LEAST €500 MILLION BY AUGUST 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
